Puma Biotechnology, Inc. (PBYI)

NASDAQ: PBYI · IEX Real-Time Price · USD

3.100

-0.180 (-5.49%)

At close: Jul 2, 2024, 4:00 PM

3.170

+0.070 (2.26%)

After-hours: Jul 2, 2024, 4:58 PM EDT

Puma Biotechnology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2007
Net Income	21.59	0	-29.13	-60	-75.6	Upgrade
Depreciation & Amortization	11.52	9.84	11.31	10.03	8.08	Upgrade
Share-Based Compensation	10.25	11.83	32.63	36.58	57.33	Upgrade
Other Operating Activities	-16.35	-37.5	5.84	14.16	32.57	Upgrade
Operating Cash Flow	27.01	-15.83	20.65	0.77	22.38	Upgrade
Operating Cash Flow Growth	-	-	2571.41%	-96.55%	-	Upgrade
Capital Expenditures	-0.14	0	0	-0.05	-0.31	Upgrade
Change in Investments	-6.49	14.1	-10.88	43.45	5.47	Upgrade
Other Investing Activities	-12.5	-7	-	-10	-	Upgrade
Investing Cash Flow	-19.13	7.1	-10.88	33.4	5.16	Upgrade
Share Issuance / Repurchase	0	12.22	0	0.07	1.35	Upgrade
Debt Issued / Paid	0	0	-11.93	0	-68.42	Upgrade
Other Financing Activities	-	-	-20	-10	-	Upgrade
Financing Cash Flow	0	12.22	-31.93	-9.93	-67.07	Upgrade
Net Cash Flow	7.88	3.5	-22.16	24.24	-39.53	Upgrade
Free Cash Flow	26.87	-15.83	20.65	0.73	22.07	Upgrade
Free Cash Flow Growth	-	-	2740.44%	-96.71%	-	Upgrade
Free Cash Flow Margin	11.40%	-6.94%	8.16%	0.32%	8.11%	Upgrade
Free Cash Flow Per Share	0.57	-0.35	0.51	0.02	0.57	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).